|
|
Volumn 38, Issue 2, 2011, Pages 171-172
|
|
Tumor heterogeneity as the foundation of personalized cancer treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY CONJUGATE;
FLUOROURACIL;
METHOTREXATE;
MICRORNA;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE INHIBITOR;
TAMOXIFEN;
BREAST CANCER;
CANCER SUSCEPTIBILITY;
CANCER THERAPY;
COPY NUMBER VARIATION;
EDITORIAL;
GENE MUTATION;
PRIORITY JOURNAL;
PROGNOSIS;
HUMANS;
INDIVIDUALIZED MEDICINE;
NEOPLASMS;
|
|
EID: 79952952463
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: 10.1053/j.seminoncol.2011.01.006 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
